GR3006955T3 - - Google Patents

Info

Publication number
GR3006955T3
GR3006955T3 GR930400212T GR930400212T GR3006955T3 GR 3006955 T3 GR3006955 T3 GR 3006955T3 GR 930400212 T GR930400212 T GR 930400212T GR 930400212 T GR930400212 T GR 930400212T GR 3006955 T3 GR3006955 T3 GR 3006955T3
Authority
GR
Greece
Application number
GR930400212T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888814438A external-priority patent/GB8814438D0/en
Priority claimed from GB888824187A external-priority patent/GB8824187D0/en
Application filed filed Critical
Publication of GR3006955T3 publication Critical patent/GR3006955T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
GR930400212T 1988-06-17 1993-02-02 GR3006955T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888814438A GB8814438D0 (en) 1988-06-17 1988-06-17 Compounds for use in medicine
GB888824187A GB8824187D0 (en) 1988-10-14 1988-10-14 Compounds for use in medicine

Publications (1)

Publication Number Publication Date
GR3006955T3 true GR3006955T3 (https=) 1993-06-30

Family

ID=26294041

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400212T GR3006955T3 (https=) 1988-06-17 1993-02-02

Country Status (12)

Country Link
EP (1) EP0347243B1 (https=)
JP (1) JPH0240325A (https=)
KR (1) KR0158870B1 (https=)
AU (1) AU623147B2 (https=)
CA (1) CA1327524C (https=)
DE (1) DE68904358T2 (https=)
DK (1) DK299089A (https=)
ES (1) ES2045437T3 (https=)
GR (1) GR3006955T3 (https=)
HU (1) HU207220B (https=)
MY (1) MY106300A (https=)
PT (1) PT90888B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
CA2056039A1 (en) * 1991-01-22 1992-07-23 Philip L. Fuchs Carbacyclin analogs
US5190972A (en) * 1992-01-27 1993-03-02 The University Of Melbourne Method of combatting cyclosporine organ toxicity with prostaglandin analogs
KR100457499B1 (ko) * 1994-04-12 2005-02-23 도레이 가부시끼가이샤 폐성심질환치료제
DE69534075T2 (de) * 1994-06-07 2005-07-21 Chugai Seiyaku K.K. Vorbeugungs- und heilmittel für erkrankungen, die durch fibrin- oder thrombusbildung hervorgerufen werden
ATE316788T1 (de) * 1995-02-27 2006-02-15 Toray Industries Medikament gegen pulmonale herzprobleme
KR20000065039A (ko) * 1997-02-27 2000-11-06 히라이 가쯔히꼬 폐순환 개선제
WO2000055314A2 (en) * 1999-03-18 2000-09-21 United Therapeutics Corporation Inhibitors of endothelin-1 synthesis
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
RU2695274C3 (ru) 1999-10-15 2020-11-09 Сукампо Аг Новые композиции и способы их стабилизации
DE602004028155D1 (de) 2003-12-16 2010-08-26 United Therapeutics Corp Verwendung von treprostinil zur behandlung von ischämischen läsionen
US20090124697A1 (en) 2003-12-16 2009-05-14 United Therapeutics Corporation Inhalation formulations of treprostinil
JP2010518122A (ja) * 2007-02-09 2010-05-27 ユナイテッド セラピューティクス コーポレーション 間質性肺疾患および喘息のためのトレプロスチニル処置
CN103181893A (zh) * 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
CA2967899C (en) 2014-12-03 2023-09-19 Steadymed Ltd Preservative-free treprostinil formulations and methods and devices for use with same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
DE3315356A1 (de) * 1982-04-30 1983-11-17 Ono Pharmaceutical Co. Ltd., Osaka Verwendung von prostaglandinanalogen
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures

Also Published As

Publication number Publication date
KR0158870B1 (ko) 1998-12-01
DK299089A (da) 1989-12-18
ES2045437T3 (es) 1994-01-16
AU623147B2 (en) 1992-05-07
HUT53524A (en) 1990-11-28
DE68904358D1 (de) 1993-02-25
EP0347243B1 (en) 1993-01-13
KR910000158A (ko) 1991-01-29
DK299089D0 (da) 1989-06-16
PT90888A (pt) 1989-12-29
PT90888B (pt) 1994-12-30
DE68904358T2 (de) 1993-07-29
JPH0240325A (ja) 1990-02-09
CA1327524C (en) 1994-03-08
AU3652889A (en) 1989-12-21
MY106300A (en) 1995-04-29
EP0347243A1 (en) 1989-12-20
HU207220B (en) 1993-03-29

Similar Documents

Publication Publication Date Title
GR3006955T3 (https=)
AU1439288A (https=)
AU1529688A (https=)
AU1550788A (https=)
AU2171188A (https=)
AU2297688A (https=)
AU7003687A (https=)
AU7157587A (https=)
AU7316987A (https=)
AU7442887A (https=)
AU7833687A (https=)
AU7922587A (https=)
AU7925887A (https=)
BG45088A1 (https=)
BG45126A1 (https=)
BG45154A1 (https=)
BG45157A1 (https=)
BG45179A1 (https=)
BG45184A1 (https=)
BG45189A1 (https=)
BG45228A1 (https=)
BG45242A1 (https=)
BG45264A1 (https=)
BG45276A1 (https=)
BG45282A1 (https=)